Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
This study has been completed.
Study NCT01177163 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on August 5, 2010. Last Updated on April 17, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Interventions listed in this trial
JNJ 28431754 300 mg/placebo
JNJ 28431754 100 mg/placebo
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers